For Immediate Release
Chicago, IL – December 30, 2011 – Four free stock picks are being made available today on Zacks.com. The industry’s leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value.
The four highlighted picks are: Chemtura Corporation (CHMT), Cardinal Health, Inc. ((CAH - Analyst Report)), HiTech Pharmacal Co, Inc. (HITK) and Gardner Denver, Inc. (GDI).
Today, Zacks is promoting its ''Buy'' stock recommendations. Four daily picks are offered free. http://at.zacks.com/?id=88
From 1988 through the present – a period that included serious corrections and recessions – the Zacks #1 Rank Stocks have nearly tripled the market with a fully documented average gain of +28% per year.
Here is a summary of today's selected stocks that are now highly rated by Zacks:
Aggressive Growth – Chemtura Corporation (CHMT)
Chemtura Corporation analysts move earnings estimates higher.
Zacks Guide to Aggressive Growth Investing (free!) - http://at.zacks.com/?id=4309
Growth & Income – Cardinal Health, Inc. ((CAH - Analyst Report))
Cardinal Health, Inc. carried its strong momentum into the first quarter of its fiscal 2012 and delivered its 9th consecutive positive earnings surprise. Analysts raised their estimates after the strong quarter for both 2012 and 2013, sending the stock to a Zacks #2 Rank (Buy).
Zacks Guide to Growth & Income Investing (free!) - http://at.zacks.com/?id=4310
Momentum – HiTech Pharmacal Co, Inc. (HITK)
HiTech Pharmacal Co, Inc. just hit a new all-time high after reporting strong Q3 results that included an impressive 35% earnings surprise. With estimates on the rise and a high industry rank, this Zacks #1 rank stock is a solid pick for momentum.
Zacks Guide to Momentum Investing (free!): http://at.zacks.com/?id=4311
Value – Gardner Denver, Inc. (GDI)
Gardner Denver, Inc. is still on track for double digit earnings growth in 2012 after posting several record quarters in 2011. This Zacks #1 Rank (strong buy) has attractive valuations with a forward P/E of 13.8.
Zacks Guide to Value Investing (free!) - http://at.zacks.com/?id=4312
How to Regularly Access Top Zacks Rank Picks for Free - http://at.zacks.com/?id=7154
Underlying the four free stock picks is a simple truth that first appeared in a Financial Analysts Journal article published in 1979. Leonard Zacks, a Ph.D. from M.I.T. found that "earnings estimate revisions are the most powerful force impacting stock prices." Zacks #1 Rank is awarded to a stock when analysts sharply upgrade their estimates of what the company will earn.
Today, Zacks is promoting its stock recommendations by offering four daily picks free to those who register here: http://at.zacks.com/?id=7155
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms. It monitors more than 200,000 earnings estimates, looking for changes.
Then, when changes are discovered, they’re applied to help assign more than 4,400 stocks into five Zacks Rank categories: #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock-picking system continues to outperform the market by a nearly 3-to-1 margin.
More Free Stock Picks
Each weekday, new Zacks #1 Rank or Zacks #2 Rank stock picks are released on the free email newsletter, Profit from the Pros. Investors are invited to register for their free subscription here: http://at.zacks.com/?id=91
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Zacks Investment Research
800-767-3771 ext. 9339
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.